The incidence of malignant mesothelioma continues to increase, but the disease remains difficult to detect early and treat effectively.
Methods
The authors review the pathogenesis, incidence, clinical presentation, diagnosis, pathology, and both standard and experimental treatments for mesothelioma.
Results
When possible, surgery (video-assisted thoracoscopy, pleurectomy/decortication, or extrapleural pneumonectomy) is utilized. Effects on underlying structures limit application of radiation therapy, but some systemic agents are beginning to enhance survival.
Conclusions
The disease is expected to increase in incidence till 2020, so awareness of this entity as a possible diagnosis should be heightened. In patients with advanced disease, several newer antitumor agents are already showing a capability of extending survival so it is not unreasonable to expect further progress in this area.
References
1.
Work-Related Lung Disease Surveillance Report 2002. NIOSH Publication No. 2003-111. National Institute for Occupational Safety and Health. Section 7. Malignant Mesothelioma. Available at http://www.cdc.gov/niosh/docs/2003-111/2003-111.html. Accessed on September 7, 2006.
2.
RobinsonB.W., LakeR.A.Advances in malignant mesothelioma. N Engl J Med.2005; 353: 1591–1603.
3.
WagnerJ.C., SleggsC.A., MarchandP.Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med.1960; 17: 260–271.
4.
CugellD.W., KampD.W.Asbestos and the pleura: a review. Chest.2004; 125: 1103–1117.
5.
CarboneM., PassH.I., MieleL.New developments about the association of SV40 with human mesothelioma. Oncogene.2003; 22: 5173–5180.
6.
Barbanti-BrodanoG., SabbioniS., MartiniF.Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology.2004; 318: 1–9.
7.
StricklerH.D., GoedertJ.J., DevesaS.S.Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst.2003; 95: 38–45.
8.
CutroneR., LednickyJ., DunnG.Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res.2005; 65: 10273–10279.
RobinsonB.W., CreaneyJ., LakeR.Mesothelin-family proteins and the diagnosis of mesothelioma. Lancet.2003; 362: 1612–1616.
11.
PassH.I., LottD., LonardoF.Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med.2005; 353: 1564–1573.
12.
van RuthS., BaasP., ZoetmulderF.A.Surgical treatment of malignant pleural mesothelioma: a review. Chest.2003; 123: 551–561.
13.
RuschV.W.Pleurectomy/decortication in the setting of multimodality treatment for diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg.1997; 9: 367–372.
14.
StewartD.J., Martin-UcarA., PillingJ.E.The effect of extent of local resection on patterns of disease progression in malignant mesothelioma. Ann Thorac Surg.2004; 78: 245–252.
ZierhutD., GutweinS., MunterM.W.Radiation therapy of mesothelioma: the Heidelberg experience and future aspects. Lung Cancer.2004; 45(suppl 1): S85–S91.
17.
VogelzangN.J., RusthovenJ.J., SymanowskiJ.Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol.2003; 21: 2636–2644.
18.
KindlerH.L., KarrisonT., LuC.A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM). Proc Annu Meet Am Soc Clin Oncol.2005; 23: 7019. Abstract.
19.
MikulskiS.M., CostanziJ.J., VogelzangN.J.Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma. J Clin Oncol.2002; 20: 274–281.
20.
PavlakisN., VogelzangN.J.Ranpirnase–an antitumour ribonuclease: its potential role in malignant mesothelioma. Expert Opin Biol Ther.2006; 6: 391–399.
21.
SugarbakerD.J., FloresR.M., JaklitschM.T.Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg.1999; 117: 54–65.
22.
LeeT.T., EverettD.L., ShuH.K.Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg.2002; 124: 1183–1189.
